Sale!

COMP Gene Epiphyseal dysplasia multiple type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COMP Gene Epiphyseal Dysplasia Multiple Type 1 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE. This test is designed to identify mutations in the COMP gene, which are known to cause Multiple Epiphyseal Dysplasia Type 1 (MED1), a rare genetic disorder affecting the development of bones and cartilage. This condition typically manifests in early childhood, leading to joint pain, malformations, and potential growth abnormalities.

By analyzing a patient’s DNA, the test aims to confirm a diagnosis of MED1, enabling healthcare providers to tailor treatment plans and offer genetic counseling based on the specific mutation present. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed to ensure accurate results. Conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing services, this test represents a crucial step for affected individuals and their families in managing and understanding the implications of Multiple Epiphyseal Dysplasia Type 1.

Description

COMP Gene Epiphyseal dysplasia multiple type 1 Genetic Test

Components: COMP Gene Epiphyseal dysplasia multiple type 1 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for COMP Gene Epiphyseal dysplasia, multiple, type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COMP Gene Epiphyseal dysplasia, multiple, type 1 NGS Genetic DNA Test gene COMP

Test Details: Epiphyseal dysplasia, multiple, type 1 (EDM1) is a rare genetic disorder that affects the growth and development of the bones in the body. It is caused by mutations in the COMP gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses high-throughput sequencing technologies to rapidly sequence large amounts of DNA. In the context of EDM1, NGS genetic testing can be used to identify mutations in the COMP gene. This can help confirm a diagnosis of the condition and provide information about the specific genetic variant causing the disease. NGS testing may also be useful for carrier testing, prenatal diagnosis, or for identifying at-risk family members. NGS genetic testing has revolutionized the field of genetics by allowing for faster and more comprehensive analysis of genetic information. It has greatly improved the efficiency and accuracy of diagnosing genetic disorders like EDM1, leading to better patient care and management.

Test Name	COMP Gene Epiphyseal dysplasia multiple type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for COMP Gene Epiphyseal dysplasia, multiple, type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COMP Gene Epiphyseal dysplasia, multiple, type 1 NGS Genetic DNA Test gene COMP
Test Details	Epiphyseal dysplasia, multiple, type 1 (EDM1) is a rare genetic disorder that affects the growth and development of the bones in the body. It is caused by mutations in the COMP gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses high-throughput sequencing technologies to rapidly sequence large amounts of DNA. In the context of EDM1, NGS genetic testing can be used to identify mutations in the COMP gene. This can help confirm a diagnosis of the condition and provide information about the specific genetic variant causing the disease. NGS testing may also be useful for carrier testing, prenatal diagnosis, or for identifying at-risk family members. NGS genetic testing has revolutionized the field of genetics by allowing for faster and more comprehensive analysis of genetic information. It has greatly improved the efficiency and accuracy of diagnosing genetic disorders like EDM1, leading to better patient care and management.